| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.61 | 1e-85 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.42 | 5e-42 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.51 | 3e-29 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.54 | 2e-28 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-26 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.5 | 4e-24 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-20 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.3 | 2e-11 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |